ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
2022年7月28日 - 5:20AM
ビジネスワイヤ(英語)
ICON plc (NASDAQ: ICLR) ) (“ICON”),
a world-leading healthcare intelligence and clinical research
organisation, today announced that all resolutions at the Annual
General Meeting of the Company (AGM) held on July 26, 2022 (which
resolutions had all been recommended by the Board) were all duly
passed by shareholders. These resolutions were set out in the
Notice of the AGM sent to shareholders dated June 17, 2022 and are
available on the ICON plc website.
Forms of Proxy were received by ICON plc before the meeting,
appointing proxies and giving them the following voting
instructions:
RESOLUTION NUMBER
RESOLUTION
TOTAL NUMBER OF VOTES
VOTE FOR
VOTE AGAINST
VOTE WITHHELD
1.1
To re-elect Dr. Steve Cutler
68,779,075
68,477,992
282,603
18,480
1.2
To re-elect Dr. John Climax
68,779,075
68,422,769
335,587
20,719
1.3
To re-elect Mr. Ronan Murphy
68,779,075
66,367,298
2,390,837
20,940
2
To receive accounts and
reports
73,569,137
68,462,797
11,999
304,279
3
To authorise the fixing of the
auditors’ remuneration
68,446,624
63,672,735
5,081,059
25,281
4
To authorise the Company to allot
shares
68,779,075
67,765,424
886,295
127,356
5**
To disapply pre-emption
rights
68,779,075
68,606,325
39,628
133,122
6**
To disapply pre-emption rights
for funding capital investment or acquisitions
68,779,075
68,556,034
92,233
130,808
7**
To authorise the Company to make
market purchases of shares
68,779,075
68,347,004
145,030
287,041
8**
To authorise the price range at
which the Company can reissue shares it holds as treasury
shares
68,779,075
68,608,764
40,897
129,414
** Special Resolution. All resolutions are ordinary resolutions
unless otherwise stated.
This AGM marks the retirement from the Board of Professor
William Hall, Ms. Mary Pendergast and Professor Hugh Brady.
Professor William Hall has served as a non-executive director of
ICON since February 2013, Ms. Mary Pendergast has served as a
non-executive director of ICON since February 2014 and Professor
Hugh Brady has served as a non-executive director of ICON since
April 2014.
“I would like to thank William, Mary and Hugh for their long and
distinguished service to ICON and for their important contributions
to the Board and to the committees on which they have served.”
commented Mr. Ciaran Murray, ICON’s Chair.
This press release contains forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, the impact of
COVID-19 on our business, as well as other economic and global
market conditions and other risks and uncertainties detailed from
time to time in SEC reports filed by ICON, all of which are
difficult to predict and some of which are beyond our control. For
these reasons, you should not place undue reliance on these
forward-looking statements when making investment decisions. The
word "expected" and variations of such words and similar
expressions are intended to identify forward-looking statements.
Forward-looking statements are only as of the date they are made
and we do not undertake any obligation to update publicly any
forward-looking statement, either as a result of new information,
future events or otherwise. More information about the risks and
uncertainties relating to these forward-looking statements may be
found in SEC reports filed by ICON, including its Form 20-F, F-1,
S-8 and F-3, which are available on the SEC's website at
http://www.sec.gov.
ICON plc is a world-leading healthcare intelligence and clinical
research organisation. From molecule to medicine, we advance
clinical research providing outsourced services to pharmaceutical,
biotechnology, medical device and government and public health
organisations. We develop new innovations, drive emerging therapies
forward and improve patient lives. With headquarters in Dublin,
Ireland, ICON employed approximately 40,500 employees in 119
locations in 53 countries as at June 30, 2022. For further
information about ICON, visit: www.iconplc.com.
Source: ICON plc
ICON/ICLR-F
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220727005904/en/
Investor Relations 1 888 381 7923 or Brendan Brennan Chief
Financial Officer + 353 1 291 2000 Kate Haven Vice President
Investor Relations +1888 381 7923 All at ICON.
ICON (NASDAQ:ICLR)
過去 株価チャート
から 6 2024 まで 7 2024
ICON (NASDAQ:ICLR)
過去 株価チャート
から 7 2023 まで 7 2024